Progestogens in women with threatened miscarriage or recurrent miscarriage: A meta-analysis.
Zhao Y, D'Souza R, Gao Y, Hao Q, Kallas-Silva L, Steen JP, Guyatt G.
Acta Obstet Gynecol Scand. 2024 Sep;103(9):1689-1701. doi: 10.1111/aogs.14829. Epub 2024 Mar 13.
Progesterone for women with threatened miscarriage (STOP trial): a placebo-controlled randomized clinical trial.
McLindon LA, James G, Beckmann MM, Bertolone J, Mahomed K, Vane M, Baker T, Gleed M, Grey S, Tettamanzi L, Mol BWJ, Li W.
Hum Reprod. 2023 Apr 3;38(4):560-568. doi: 10.1093/humrep/dead029.
Efficacy and safety of different progestogens in women with first threatened miscarriage: A network meta-analysis.
Zhao H, He W, Xia C, Yang Z.
Int J Gynaecol Obstet. 2025 Mar;168(3):944-957. doi: 10.1002/ijgo.15987. Epub 2024 Dec 19.
Efficacy of progesterone on threatened miscarriage: Difference in drug types.
Wang XX, Luo Q, Bai WP.
J Obstet Gynaecol Res. 2019 Apr;45(4):794-802. doi: 10.1111/jog.13909. Epub 2019 Jan 10.
Efficacy of progesterone on threatened miscarriage: an updated meta-analysis of randomized trials.
Yan Y, Chen Z, Yang Y, Zheng X, Zou M, Cheng G, Yuan Z.
Arch Gynecol Obstet. 2021 Jan;303(1):27-36. doi: 10.1007/s00404-020-05808-8. Epub 2020 Sep 28.
Threatened miscarriage: evaluation and management.
Sotiriadis A, Papatheodorou S, Makrydimas G.
BMJ. 2004 Jul 17;329(7458):152-5. doi: 10.1136/bmj.329.7458.152.
Progestogen for treating threatened miscarriage.
Wahabi HA, Fayed AA, Esmaeil SA, Bahkali KH.
Cochrane Database Syst Rev. 2018 Aug 6;8(8):CD005943. doi: 10.1002/14651858.CD005943.pub5.
Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence.
Coomarasamy A, Devall AJ, Brosens JJ, Quenby S, Stephenson MD, Sierra S, Christiansen OB, Small R, Brewin J, Roberts TE, Dhillon-Smith R, Harb H, Noordali H, Papadopoulou A, Eapen A, Prior M, Di Renzo GC, Hinshaw K, Mol BW, Lumsden MA, Khalaf Y, Shennan A, Goddijn M, van Wely M, Al-Memar M, Bennett P, Bourne T, Rai R, Regan L, Gallos ID.
Am J Obstet Gynecol. 2020 Aug;223(2):167-176. doi: 10.1016/j.ajog.2019.12.006. Epub 2020 Jan 31.
Oral dydrogesterone for prevention of miscarriage in threatened miscarriage: a randomized, double-blind, placebo-controlled trial.
Kuptarak A, Phupong V.
J Matern Fetal Neonatal Med. 2024 Dec;37(1):2333929. doi: 10.1080/14767058.2024.2333929. Epub 2024 Apr 3.
Progestogen therapy in threatened miscarriage and unexplained recurrent pregnancy loss: Recommendations by the Thai interest group.
Kongwattanakul K, Jatavan P, Musigavong O, Pranpanus S, Salang L, Satirapod C, Petyim S, Uerpairojkit B.
J Obstet Gynaecol Res. 2025 Aug;51(8):e70038. doi: 10.1111/jog.70038.
